HA
HALOZYME THERAPEUTICS, INC.
Nasdaq : HALOHealthcare · Biological Products, (No Diagnostic Substances)
Mkt Cap$12.76BShares Out113.50M30d Avg Vol24.74MShort Int—Short Float—IPOMar 12, 2004
▲+0.74%
$9.51
Financials Summary
Revenue$1.40B
Net Income$316.89M
Total Assets$2.53B
Free Cash Flow$644.59M
Debt & Equity
Debt 98% Equity 2%
Total Debt$2.14B
Total Equity$48.81M
Shares Outstanding
Current O/S3.10B
4B3B2B1B0
Q3 '16Q2 '18Q4 '19Q3 '21Q1 '23Q4 '24Current
Short Interest
Shares Short39.82M
50M37.5M25M12.5M0
Dec 12Jan 23Mar 6Apr 10May 22Jul 3
Balance Sheet Details
Assets$2.53B
Liabilities$2.48B
Accounts Receivable$426.27M
Accounts Payable$20.90M
Inventory$176.47M
PP&E (Net)$44.44M
Goodwill$580.36M
Intangible Assets$981.47M
Cash Position Chart
$750M$563M$375M$188M$0
Q3 '16Q1 '18Q2 '19Q4 '20Q1 '22Q3 '23Q4 '24Q2 '26
Current Cash$133.82M